These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3711613)

  • 21. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.
    Rudolph R; Larson DL
    J Clin Oncol; 1987 Jul; 5(7):1116-26. PubMed ID: 3298560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and treatment of chemotherapy extravasation injuries.
    Kassner E
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):135-48. PubMed ID: 10944862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of toxicity of intravitreal antineoplastic drugs.
    Peyman GA; Greenberg D; Fishman GA; Fiscella R; Thomas A
    Ophthalmic Surg; 1984 May; 15(5):411-3. PubMed ID: 6203076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for Management of Noncytotoxic Vesicant Extravasations.
    Ong J; Van Gerpen R
    J Infus Nurs; 2020; 43(6):319-343. PubMed ID: 33141794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Soft-tissue defects on the dorsum of the hand by extravasation of the cytostatic agents: surgical options of treatment].
    Damert HG; Lenz-Scharf O; Altmann S; Schneider W
    Handchir Mikrochir Plast Chir; 2007 Dec; 39(6):409-13. PubMed ID: 18058671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vesicant chemotherapy extravasation antidotes and treatments.
    Schulmeister L
    Clin J Oncol Nurs; 2009 Aug; 13(4):395-8. PubMed ID: 19648094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of perivascular extravasation of cytostatic agents].
    Rauh J; Pluntke S; Müller Ch
    MMW Fortschr Med; 2004 Aug; 146(31-32):23-4, 26-7. PubMed ID: 15529703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of heparin fractions on the prevention of skin necrosis resulting from adriamycin extravasation: an experimental study.
    Askar I; Erbas MK; Gurlek A
    Ann Plast Surg; 2002 Sep; 49(3):297-301. PubMed ID: 12351979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin and perivascular toxicity induced experimentally by doxorubicin.
    Balsari A; Lombardo N; Ghione M
    J Chemother; 1989 Oct; 1(5):324-9. PubMed ID: 2585034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental skin necrosis produced by adriamycin.
    Rudolph R; Suzuki M; Luce JK
    Cancer Treat Rep; 1979 Apr; 63(4):529-37. PubMed ID: 445507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor.
    MacDonald JR; Pegg DG
    Cancer Chemother Pharmacol; 1993; 32(5):365-7. PubMed ID: 8339386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenomedullin worsens skin necrosis in rats subjected to vincristine-induced extravasation.
    Kesik V; Kurt B; Tunc T; Karslioglu Y; Citak EC; Kismet E; Koseoglu V
    Clin Exp Dermatol; 2010 Dec; 35(8):897-901. PubMed ID: 20345993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage.
    Theman TA; Hartzell TL; Sinha I; Polson K; Morgan J; Demetri GD; Orgill DP; George S
    J Clin Oncol; 2009 Nov; 27(33):e198-200. PubMed ID: 19805684
    [No Abstract]   [Full Text] [Related]  

  • 35. Antidote studies of vinorelbine-induced skin ulceration in the mouse.
    Dorr RT; Bool KL
    Cancer Chemother Pharmacol; 1995; 36(4):290-2. PubMed ID: 7628047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and management of extravasation of cytotoxic drugs.
    Bertelli G
    Drug Saf; 1995 Apr; 12(4):245-55. PubMed ID: 7646823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possibility of Taking an Offensive Stance in Extravasation Injury: Effects of Fat Injection in Vesicant (Doxorubicin) Induced Skin Necrosis Model in Rats.
    Bicer A; Ercin BS; Gürler T; Yiğittürk G; Uyanikgil Y; Cetin EO
    J Invest Surg; 2022 Apr; 35(4):801-808. PubMed ID: 34402353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradermal carboplatin and ifosfamide extravasation in the mouse.
    Marnocha RS; Hutson PR
    Cancer; 1992 Aug; 70(4):850-3. PubMed ID: 1643617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extravasation of systemic hemato-oncological therapies.
    Ener RA; Meglathery SB; Styler M
    Ann Oncol; 2004 Jun; 15(6):858-62. PubMed ID: 15151940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitomycin C extravasation ulcers.
    Khanna AK; Khanna A; Asthana AK; Misra MK
    J Surg Oncol; 1985 Feb; 28(2):108-10. PubMed ID: 3918215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.